Market Map

Define patient segmentation. Map AD patient types → pipeline assets → share assumptions.

Total Addressable Patients

6.8M

Patient Segments

8

Assets Mapped

4

KP-723

(STAT6)
2.52M patients

Moderate AD — Oral-Seeking

2100K patients · Adult · Moderate · 7% share

Adolescent — Oral Preference

420K patients · Adolescent · Moderate · 5% share

NM-26

(IL-4Rα × IL-31Rα)
2.63M patients

Severe AD — Biologic Naïve

1400K patients · Adult · Severe · 9% share

Severe AD — Itch-Dominant

650K patients · Adult · Severe · 12% share

Adolescent Moderate-Severe AD

580K patients · Adolescent · Severe · 6% share

PX-128

(IL-13 × TSLP)
0.82M patients

Severe AD — Dupixent IR

480K patients · Adult · Severe · 8% share

Early Pediatric AD

340K patients · EarlyPediatric · Severe · 4% share

PX-130

(IL-13 × IL-22)
0.82M patients

Moderate AD — Barrier Dysfunction

820K patients · Adult · Moderate · 5% share